Cyberounds Logo
December 12, 2018 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Scleroderma
CME credit is no longer available for this conference.
Meggan Mackay, M.D., M.S., and Peter Barland, M.D.

Dr. Mackay is an Assistant Professor of Medicine at Albert Einstein College of Medicine.

Dr. Mackay reports no conflict of interest. Dr. Barland reports no conflict of interest.


Release Date: 08/20/2004
Termination Date: 08/20/2007

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Describe the clinical manifestations and course of diffuse cutaneous scleroderma (dcSSc)
  • Describe the clinical manifesations and course of localized cutaneous scleroderma (CREST)
  • Discuss the possible pathogenesis of scleroderma as well as the current therapeutic options available for the different clinical syndromes associated with dcSSc and CREST.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity